223 related articles for article (PubMed ID: 32341038)
1. Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome.
Yokomizo-Nakano T; Kubota S; Bai J; Hamashima A; Morii M; Sun Y; Katagiri S; Iimori M; Kanai A; Tanaka D; Oshima M; Harada Y; Ohyashiki K; Iwama A; Harada H; Osato M; Sashida G
Cancer Res; 2020 Jun; 80(12):2523-2536. PubMed ID: 32341038
[TBL] [Abstract][Full Text] [Related]
2. Two faces of RUNX3 in myeloid transformation.
Yokomizo-Nakano T; Sashida G
Exp Hematol; 2021 May; 97():14-20. PubMed ID: 33600870
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
Bai J; Yokomizo-Nakano T; Kubota S; Sun Y; Kanai A; Iimori M; Harada H; Iwama A; Sashida G
Oncogene; 2021 Feb; 40(8):1531-1541. PubMed ID: 33452460
[TBL] [Abstract][Full Text] [Related]
4. Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.
Matsuura S; Komeno Y; Stevenson KE; Biggs JR; Lam K; Tang T; Lo MC; Cong X; Yan M; Neuberg DS; Zhang DE
Blood; 2012 Nov; 120(19):4028-37. PubMed ID: 22919028
[TBL] [Abstract][Full Text] [Related]
5. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
Song SJ; Ito K; Ala U; Kats L; Webster K; Sun SM; Jongen-Lavrencic M; Manova-Todorova K; Teruya-Feldstein J; Avigan DE; Delwel R; Pandolfi PP
Cell Stem Cell; 2013 Jul; 13(1):87-101. PubMed ID: 23827711
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
7. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
8. Transcription Factors Runx1 and Runx3 Suppress Keratin Expression in Undifferentiated Keratinocytes.
Ogawa E; Edamitsu T; Ohmori H; Kohu K; Kurokawa M; Kiyonari H; Satake M; Okuyama R
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077435
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
Oncogene; 2005 Mar; 24(11):1873-81. PubMed ID: 15688019
[TBL] [Abstract][Full Text] [Related]
10. Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity.
Aho TL; Sandholm J; Peltola KJ; Ito Y; Koskinen PJ
BMC Cell Biol; 2006 May; 7():21. PubMed ID: 16684349
[TBL] [Abstract][Full Text] [Related]
11. Runx1 downregulates stem cell and megakaryocytic transcription programs that support niche interactions.
Behrens K; Triviai I; Schwieger M; Tekin N; Alawi M; Spohn M; Indenbirken D; Ziegler M; Müller U; Alexander WS; Stocking C
Blood; 2016 Jun; 127(26):3369-81. PubMed ID: 27076172
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.
Sun J; He X; Zhu Y; Ding Z; Dong H; Feng Y; Du J; Wang H; Wu X; Zhang L; Yu X; Lin A; McDonald T; Zhao D; Wu H; Hua WK; Zhang B; Feng L; Tohyama K; Bhatia R; Oberdoerffer P; Chung YJ; Aplan PD; Boultwood J; Pellagatti A; Khaled S; Kortylewski M; Pichiorri F; Kuo YH; Carlesso N; Marcucci G; Jin H; Li L
Cell Stem Cell; 2018 Sep; 23(3):355-369.e9. PubMed ID: 30146412
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of RUNX3 inhibits normal human myeloid development.
Menezes AC; Jones R; Shrestha A; Nicholson R; Leckenby A; Azevedo A; Davies S; Baker S; Gilkes AF; Darley RL; Tonks A
Leukemia; 2022 Jul; 36(7):1769-1780. PubMed ID: 35490198
[TBL] [Abstract][Full Text] [Related]
14. Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders.
Muto T; Sashida G; Oshima M; Wendt GR; Mochizuki-Kashio M; Nagata Y; Sanada M; Miyagi S; Saraya A; Kamio A; Nagae G; Nakaseko C; Yokote K; Shimoda K; Koseki H; Suzuki Y; Sugano S; Aburatani H; Ogawa S; Iwama A
J Exp Med; 2013 Nov; 210(12):2627-39. PubMed ID: 24218139
[TBL] [Abstract][Full Text] [Related]
15. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
Tsai SC; Shih LY; Liang ST; Huang YJ; Kuo MC; Huang CF; Shih YS; Lin TH; Chiu MC; Liang DC
Clin Cancer Res; 2015 Aug; 21(15):3541-51. PubMed ID: 25840971
[TBL] [Abstract][Full Text] [Related]
16. Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects.
Wang CQ; Krishnan V; Tay LS; Chin DW; Koh CP; Chooi JY; Nah GS; Du L; Jacob B; Yamashita N; Lai SK; Tan TZ; Mori S; Tanuichi I; Tergaonkar V; Ito Y; Osato M
Cell Rep; 2014 Aug; 8(3):767-82. PubMed ID: 25066130
[TBL] [Abstract][Full Text] [Related]
17. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
[TBL] [Abstract][Full Text] [Related]
18. Runx3 deficiency results in myeloproliferative disorder in aged mice.
Wang CQ; Motoda L; Satake M; Ito Y; Taniuchi I; Tergaonkar V; Osato M
Blood; 2013 Jul; 122(4):562-6. PubMed ID: 23741011
[TBL] [Abstract][Full Text] [Related]
19. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
20. Runx1 and Runx3 drive progenitor to T-lineage transcriptome conversion in mouse T cell commitment via dynamic genomic site switching.
Shin B; Hosokawa H; Romero-Wolf M; Zhou W; Masuhara K; Tobin VR; Levanon D; Groner Y; Rothenberg EV
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33479171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
